sodium chloride infusion

DRUG3 trials

Sponsors

Boehringer Ingelheim, Ospedale Misericordia e Dolce

Conditions

Acute Kidney InjuryHealthy

Phase 1

Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BI 653048 BS H3PO4 Capsule Assessing Endotoxin-induced Inflammatory Response in Healthy Male Subjects

CompletedNCT02224105

Boehringer IngelheimHealthy

Start: 2010-03-31Updated: 2014-08-25

Phase 4

Personalized Versus Standard Hydration for Prevention of CI-AKI: a Randomized Trial With Bioimpedance Analysis

CompletedNCT02225431

Ospedale Misericordia e DolceAcute Kidney Injury

Start: 2012-09-30End: 2015-04-30Updated: 2015-10-16

Unknown Phase

Tailored Hydration Based on Bioimpedance Analysis for Prevention of Contrast Induced Acute Kidney Injury

Ospedale Misericordia e DolceAcute Kidney Injury

Start: 2016-05-01End: 2019-12-31Target: 1000Updated: 2020-01-02

Related Papers

Clinical profile of the functionally selective glucocorticoid receptor agonist BI 653048 in healthy male subjects.

2019-04-095 citations

Bioimpedance-Guided Hydration for the Prevention of Contrast-Induced Kidney Injury: The HYDRA Study.

2018-06-0148 citations